Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose S(+)-ketamine effects on DNIC and offset analgesia in chronic pain and healthy volunteers
NL-OMON33040Phase 4Active, not recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of esketamine in Complex Regional Pain Syndrome Type 1 (CRPS-1), fibromyalgia (FM) and Neuralgia (4 arms), sponsored by Leiden University Medical Center. Primary endpoints: Effect of ketamine on DNIC and offset analgesia pain measurements, Baseline DNIC and offset analgesia in chronic pain groups and 1 more. Started Aug 2010; status: active, not recruiting.
02
Drugs
esketamine
03
Conditions
Complex Regional Pain Syndrome Type 1 (CRPS-1)fibromyalgia (FM)Neuralgia
Beyond the preview
Go deeper on NL-OMON33040.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON33040.